Serum from patients with nonapparent DR tended to present higher levels of Reg-3a than healthy controls (p = 0.008), and serum from patients with advanced NPDR/PDR presented higher Reg-3a levels than controls (p = 0.008). The gene discussed is REG3A; the disease is non-proliferative diabetic retinopathy.